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Abstract.  Deregulation of molecular pathways control- 
ling cell survival and death, including programmed cell 
death, are thought to be important factors in tumor for- 
mation, disease progression, and response to therapy. 
Studies devoted to analyzing the role of programmed 
cell death in cancer have been carried out primarily us- 
ing conventional monolayer cell culture systems. How- 
ever the majority of cancers grow as three-dimensional 
solid tumors. Because gene expression, and possibly 
function, can be significantly altered under such condi- 
tions, we decided to analyze the control and character- 
istics of cell death using a compatible three-dimen- 
sional tissue culture system (multicellular spheroids) 
and compare the results obtained to those using two- 
dimensional monolayer cell culture. To do so we se- 
lected for study an immortalized, but nontumorigenic 
line of rat intestinal epithelial cells, called IEC-18, and 
several tumorigenic variants of IEC-18 obtained by 
transfection with a mutant (activated) c-H-ras onco- 
gene. The rationale for choosing these cell lines was 
based in part on the fact that intestinal epithelial cells 
grow in vivo in a monolayer-like manner and form solid 
tumors only after sustaining certain genetic mutations, 
including those involving the ras gene family. We found 
that the IEC-18 cells, which grow readily and survive in 
monolayer cell culture, undergo massive cell death 
within 48-72 h when cultured as multicellular spheroids 
on a nonadhesive surface. This process was accompa- 
nied by a number of features associated with pro- 
grammed cell death including chromatin condensation 
(Hoechst 33258 staining) apoptotic morphology, DNA 
degradation, and a virtual complete loss of colony 
forming (clonogenic) ability in the absence of apparent 
membrane damage as well as accumulation of lipid con- 
taining vacuoles in the cytoplasm. Moreover, enforced 
over-expression of a transfected bcl-2 gene could pre- 
vent this cell death process from taking place. In 
marked contrast, three different stably transfected ras 
clones of IEC-18 survived when grown as multicellular 
spheroids. In addition, an IEC cell line (called clone 25) 
carrying its mutant transfected ras under a glucocorti- 
coid inducible promoter survived in three-dimensional 
culture only when the cells were exposed to dexa- 
methasone. If exposure to dexamethasone was delayed 
for as long as 48 h the cells nevertheless survived, 
whereas the cells became irreversibly committed to 
programmed cell death (PCD) if exposed to dexa- 
methasone after 72 h. These results suggest that intesti- 
nal epithelial cells may be programmed to activate a 
PCD pathway upon detachment from a physiologic 
two-dimensional monolayer  configuration, and that this 
process of adhesion regulated programmed cell death 
(ARPCD) can be substantially suppressed by expres- 
sion of a mutant ras oncogene. As such, mutant ras on- 
cogenes may contribute to tumorigenesis not only 
through their ability to promote cell proliferation, but 
also as direct, or indirect facilitators of cell survival and 
three-dimensional growth in certain types of solid 
tumor such as colon carcinoma. 
T 
HERE are several reasons for the current intense in- 
terest in the contribution of programmed cell death, 
or apoptosis,  in cancer development and progres- 
sion (4, 35, 52, 73, 87). The first is the recognition that the 
spontaneous expansion of tumor cell numbers in growing 
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could be an effective means of conferring upon them a rel- 
ative growth/survival advantage. Second, the toxic effects 
of many anti-cancer agents, including chemicals, radiation 
and various biologicals, can be mediated to a  significant 
extent by induction of programmed cell death (2,  16, 24, 
34, 73, 80). Consequently, genetic or epigenetic alterations 
in tumor cells that suppress their relative vulnerability to 
undergoing therapy-induced programmed cell death may 
be viewed as a generic therapeutic resistance mechanism, 
which might be therapeutically reversible, (24, 54, 73, 80). 
The bcl-2 oncogene family in mammalian cells has at- 
tracted the greatest degree of attention in terms of regula- 
tors of programmed cell death in normal and cancerous 
cells (73, 80). Some members of this gene family, such as 
bcl-2, bag-t and bcl-xc, act as suppressors of programmed 
cell death  whereas  others,  such  as  bax,  bcl-xs,  bak,  and 
bad, can promote the process (5, 12, 17, 36, 39, 60, 83, 89). 
Thus, experimental over expression of the bcl-2 or the bcl-XL 
gene products in tumor cell populations can increase their 
relative resistance to a variety of anti-cancer therapeutic 
drugs, or other toxic agents (14, 15, 54). Similar to bcl-2 
overexpression, the presence of mutant  p53  tumor sup- 
pressor gene (50, 82), or the absence of wild-type p53 al- 
leles is associated with increased resistance of tumor cells 
to apoptosis induced by DNA-damaging agents including 
drug or radiation treatment, either in vitro (49) or in vivo 
(50). 
In comparison to the bcl-2 gene family, the cell survival 
promoting role of various other common dominantly act- 
ing oncogenes is thought to be relatively minor (11, 61). A 
case in point is the ras family of mutant oncogenes. They 
are thought to contribute to cancer development and pro- 
gression  mainly through their effects on promoting cell 
proliferation, which in turn is related to their pivotal role 
in key intracellular signal transduction pathways, particu- 
larly the raf-1/MAP kinase signaling pathway (65). How- 
ever, there have been some reports that have suggested ras 
oncogenes may also function as regulators of programmed 
cell death, possibly acting indirectly in certain contexts as a 
suppressive  influence.  In  particular,  Wyllie  and  his  col- 
leagues have noted an association in transplantable mouse 
solid tumors between mutant ras oncogene expression and 
reduced levels of programmed cell death in vivo (1,  87, 
88).  In addition, the apoptotic death that is observed to 
take place in certain normal epithelial cells, as a result of 
disruption  of integrin  mediated  interaction  with  a  sur- 
rounding extracellular matrix, can be circumvented by en- 
forced expression of v-H-ras (27), and mutant H-ras can 
prevent E1A-induced apoptosis in primary baby rat kid- 
ney (BRK)  1 cells (47). Dominant negative mutants of ras 
oncogenes have also been shown to enhance programmed 
cell death when transfected into erythroleukemia cells (76). 
In some cases the apoptosis inhibiting effects of mutant ras 
genes may be mediated indirectly through regulating mem- 
bers of the bcl-2 gene family, including bcl-2 itself (41). 
Much of the analysis dealing with the genetic regulation 
of programmed cell death in tumor cells has been under- 
taken  using  cell lines  grown in  conventional monolayer 
1. Abbreviations used in this paper: AR, apoptosis-resistant; ARPCD, ad- 
hesion-regulated programmed cell death; BRK, baby rat kidney; ECM, 
extracellular matrix; PCD, programmed cell death. 
cell culture conditions. Given the fact that gene expression 
and function can be significantly altered by three-dimen- 
sional growth and multiceUular contact (25, 38, 46, 48, 85, 86) 
and that most cancers grow as solid (three-dimensional) 
tumors, we  decided to analyze the possible  mechanisms 
regulating  programmed  cell  death  in  tumors  grown  as 
three-dimensional, multicellular spheroids--as opposed to 
monolayer cell cultures only. Our decision to do so was in- 
fluenced in part by recent findings in our laboratory that 
suggested that the survival of tumor cells after single or 
multiple exposures to toxic concentrations of various anti- 
cancer  chemotherapeutic  drugs  could  be  enhanced  by 
multicellular growth conditions (29,  38, 42). The basis of 
this multicellular drug resistance is unknown, but clearly 
could involve survival mechanisms that are regulated dif- 
ferently in three-dimensional (multicellular) versus two- 
dimensional (unicellular) tissue culture conditions (38). 
The main purpose of the present study was to analyze 
the contribution of mutant c-H-ras to suppression of pro- 
grammed cell death in transformed epithelial cells, using a 
rat intestinal epithelial cell line known as IEC-18. These 
cells grow in an immortalized fashion in monolayer culture 
but are not tumorigenic and cannot form colonies in soft 
agar; these traits are acquired, however, by transfection of 
an activated H-ras oncogene (9). We decided to address 
the following questions: (a) can the IEC-18 cells grow in a 
three-dimensional manner as multicellular spheroids? (b) 
If not, do the cells die of programmed cell death, and can 
this be prevented by expression of mutant c-H-ras? 
Materials and Methods 
Cell Lines and Culture Condition 
Spontaneously immortalized IEC-18  cells were  originally derived from 
the new born rat intestine as described by Quaroui and Isselbacher (68). 
This cell line and all its derivatives were maintained as monolayers in me- 
dium composed of c~MEM  base supplemented with 5%  FBS  (GIBCO 
BRL, Gaithersburg, MD), 4 mM L-glutamine, 20 mM glucose, 10 Ixg ml-i 
insulin (Sigma Chem. Co., St. Louis, MO). All the transfectants were peri- 
odically treated with 200 ixg/ml G418 (Geneticin; GIBCO BRL) or Hy- 
gromycin B  (Boehringer Mannheim Corp., Mannheim, Germany). Deri- 
vation  of  clones  ras-3,  ras-4,  and  ras-7  constitutively  expressing  an 
activated human H-ras oncogene was described previously (9). Character- 
istics of clone 25 cells derived from IEC-18 cell line transfected with H-ras 
gene under control of the glucocorticoid-inducible MMTV long terminal 
repeat promoter were described elsewhere (23). In the latter case the ex- 
pression of H-ras can be induced by addition of 10 -6 M  dexamethasone 
acetate (Sigma) into the culture medium. This produces a visible change 
in cell morphology within 3-6 d in monolayer and within 15-48 h in spher- 
oid culture. The ras-7A3H clone  (an antisense CD44 transfectant) was 
generated and characterized by Jamal and Filmus (unpublished observa- 
tions). A pool of ras-7-derived clones has been screened in the homotypic 
aggregation assay and A3H cell line was selected on the basis of its nonag- 
gregating  properties.  IEC 18  variants  spontaneously resistant  to  pro- 
grammed cell death were isolated through a serial passage of the parental 
IEC-I8 cells on agarose-coated dishes (see below).  The spheroids were 
initially incubated for four days and then pooled and replated on plastic 
until the cells were recovered and expanded. The cycle was repeated 4-10 
times with increase in both duration of spheroid culture and yield of sur- 
viving cells. The resulting variants were designated as apoptosis-resistant 
(AR) cell lines. Three such cell lines were derived simultaneously (AR-1, 
AR-2, and AR-3) with some differences in duration of selection and re- 
covery periods. For the purpose of this study the AR-1 cells were used af- 
ter 7(AR-1.7) or 10 cycles (AR-I.10) of selection for survival in spheroid 
culture. Also cell lines AR-3.4 (4 cycles) and AR-2.10 (10 cycles) were 
used for some of our studies. Before such experiments the cells were pas- 
saged several times in monolayer to avoid transient alterations that could 
conceivably be induced in spheroid culture. 
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Multicellular spheroids were generated by the liquid overlay technique as 
described previously (42, 74). In brief, 96- or 24-well tissue culture plates 
or  100-mm plastic dishes (Costar Corp.,  Cambridge, MA) were coated 
with 50 ixL, 250 p~L or 5 mL, respectively, of prewarmed 1% SeaPlaque 
agarose solution in serum free aMEM (FMC Corp., Rockland, ME). Af- 
ter the agarose was allowed to solidify and to form a thin layer with a gen- 
tle meniscus on the bottom of the dish (~60 min), a single cell suspension 
of cells (usually an equivalent of 105  ceils per well of the 24-well plate) 
was plated in complete growth medium into each well. The plates were 
swirled gently to allow cell-to-cell contact and incubated undisturbed in 
humidified atmosphere at 37°C, 5%CO2 for at least 24 h. Clone 25 cells 
were induced to express mutant H-ras by addition of 10  -6 M dexametha- 
sone on the day of cell plating or at time points, as indicated. The drug was 
also added to parental IEC-18 cells (control) without any visible effect on 
the cells. 
Monitoring of Cell Growth and Viability 
The cells plated in spheroid culture and in parallel monolayers were in- 
spected daily, photographed, and when indicated, analyzed for their col- 
ony forming ability (colony formation assay), DNA content and DNA in- 
tegrity (FACS, gel electrophoresis), cell membrane integrity (trypan blue 
exclusion, morphology), metabolic activity, and other parameters of growth 
and viability. 
Colony Formation ( Clonogenic Survival) Assay 
The ability of cells to form clonal colonies on plastic was analyzed as de- 
scribed previously (70).  A  putative single cell suspension was prepared 
from either  pooled  spheroids or  corresponding monolayer cultures by 
treatment with trypsin-EDTA solution. In some cases the compact IEC-18 
spheroids were dispersed by treatment with an enzyme cocktail containing 
1 mg m1-1 Collagenase (CLS 3; Worthington Biochem. Corp., Freehold, 
N J), 0.5 mg ml  "1 Hyaluronidase, 0.5 mg m1-1 Collagenase type IV and 15 U 
ml  "1 Elastase (all three purchased from Sigma). In the time course experi- 
ments the cell recovery was calculated as the total number of cells/well di- 
vided by the number of cells plated on day 0. Different numbers of trypan 
blue excluding cells from each sample were plated onto triplicate 100-mm 
tissue culture dishes (Costar) in complete growth medium and incubated 
for 7-10 d. The resulting clonal colonies were then fixed in Carnoy's fixa- 
tive (methanol/acetic acid, 2:1 vol/vol), stained with crystal violet solution 
and counted (only those containing more than 30 cells) under dissecting 
microscope. The colony forming ability calculated as the number of colo- 
nies/plate divided by the number of cells plated (×  100%) was averaged 
across all the countable plates. 
FA  CS Analysis 
Single cell suspensions were prepared as described above. The cells were 
washed in Ca2+Mg2+-free PBS and fixed in cold ethanol/PBS (1:1 vol/vol). 
The fixative was removed by centrifugation and the cells washed with 
PBS, incubated with RNAseA (15 KU m1-1) and stained with propidium 
iodide at the final concentration of 50 p.g m1-1. The samples were ana- 
lyzed for the DNA content and cell cycle profile by using FACScan flow 
cytometer (Becton Dickinson, San Francisco, CA). The red fluorescence 
was excited at 488 nm wave length of the Argon laser beam. The data ac- 
quisition and analysis was performed by using the standard LYSIS II soft- 
ware. 
DNA Electrophoresis 
Spheroids were cultured for different periods of time and pooled (,'~107 
cells per sample). The spheroid samples were pelleted and lysed with 1% 
Triton X-100, 3 uM MgCl2 and 10 mM Tris, pH 8.0,  digested overnight 
with proteinase K  (200 p.g m1-1) in 0.5% SDS and with RNAse A. The 
DNA was extracted with phenol/chloroform and ethanol precipitated, and 
heated at 65°C for 10 min. The samples were resolved in 1.2% agarose gel 
containing ethidium bromide. 
Morphological Analysis of  Apoptotic Cells 
The dying cells recovered from IEC-18 spheroids at different time points 
were examined in the presence of trypan blue under high magnification 
(400 ×) by using a Zeiss Axiovert 135 microscope (Carl Zeiss, Inc. Thorn- 
wood, NY). Separate cell aliquots were fixed in methanol/acetic acid solu- 
tion (3:1  vol/vol) and stained for 10-30 min with the DNA-binding dye 
Hoechst 33258  (added  directly  to  the  fixative). The  ceils were  subse- 
quently washed with PBS placed on microscope slides and the fluores- 
cence of the nuclei was examined using Zeiss Axiovert 135  microscope 
equipped with an appropriate UV filter. For the electron microscopy ex- 
periments, the single cell suspensions from monolayers or pooled intact 
spheroids were gently pelleted in Eppendorf tubes and fixed with buffered 
paraformaldehyde. The pellets were then removed, sectioned, and pro- 
cessed for electron microscopy. The specimens were viewed and photo- 
graphed under different magnifications by using a Zeiss electron micro- 
scope. 
MTI" Assay 
Cell survival was monitored indirectly by assessment of their metabolic 
activity in the standard MTT assay. The cells (1-2 ×  105/well) were plated 
in agarose coated 24-well plates. At various time points the MTT reagent 
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium  bromide) in PBS was 
added to triplicate wells to the final concentration of I mg ml  -l. After 4-h 
incubation individual spheroids surrounded with formazan crystals were 
transferred into 1.5-ml Eppendorf tubes, washed with PBS, and the crys- 
tals dissolved by addition  of 100%  DMSO  for 20  min with occasional 
shaking. Aliquots of formazan solution (150 uL) were transferred into 96- 
well plates and their absorbance at 540 nm measured using MR5000 Mul- 
tiscanner (Dynatech Labs., Inc., Chantilly, VA). The results obtained by 
using this assay were in agreement with measurement of histone-DNA 
complexes in culture supernatants of IEC-18 spheroids (Cell Death De- 
tection ELISA; Boehringer Mannheim Corp.). 
DNA Transfections 
Transfections of  IEC-18  cells with  H-ras  containing vectors  were  de- 
scribed elsewhere (23, 37). Human bcl-2 was transfected into IEC-18 cells 
in the expression vector pBCL2-wt (64) containing the hygromycin resis- 
tance gene (a gift from Dr. Bert Vogelstein, Johns Hopkins University, 
Baltimore, MD) by using lipofectin reagent (GIBCO BRL). As a control, 
the corresponding empty vector pCEP4 (Invitrogen, San Diego, CA) was 
used. Clones resistant to 200 ixg m1-1 Hygromycin B  (Boehringer Mann- 
heim Corp.) were isolated and screened for expression of BCL-2 protein 
by Western analysis (see below). Clones that did not express detectable 
levels of the protein were used as additional controls. 
Western Analysis 
To detect the expression of BCL-2 or BCL-XL proteins, the cells were 
harvested from monolayer cultures, pelleted, and lysed at 4°C with 1% 
Triton X-100 in PBS in the presence of PMSF. The lysates were centri- 
fuged at 12,000 g for 20 rain,  supernatants removed and assayed for pro- 
tein concentration using the Bradford method. After the protein concen- 
trations were  adjusted, the samples were mixed with 2  ×  nonreducing 
SDS containing sample buffer and boiled for 3 rain. Equal amounts of 
protein were resolved on 12.5 % SDS-PAGE and electro-transferred to ni- 
trocellulose membrane. The membranes were blocked with 5 % skim milk 
and incubated with anti-human BCL-2 rabbit polyclonal antibody CN-19 
(Santa Cruz Biotechnology Inc., Santa Cruz, CA). This antibody is also 
able to recognize rat BCL-2 protein that in parental IEC-18 cells was not 
detectable. As a positive control for BCL-2 expression the human neuro- 
blastoma cell line SHZ-3-2-5 was used (15)  (gift from Dr. V. P. Castle, 
University  of  Michigan,  Ann  Arbor,  MI).  Alternatively,  blots  were 
probed  with mouse monoclonal anti-human BCL-X  antibody that de- 
tected appreciable levels of the BCL-XL protein in both IEC-18 cells and 
AR cell lines or with anti-RAS mouse monoclonal antibody (Transduc- 
tion Labs., Lexington, KY). The signal was detected by using Horseradish 
Peroxidase conjugated, goat anti-rabbit IgG (1:1000,  Bio-Rad) antibody 
(or for bcl-x an appropriate anti-mouse IgG antibody) and  the chemilu- 
minescence ECL kit (Amersham Corp., Arlington Heights, IL). 
Results 
Intestinal Epithelial Cells Expressing 
Oncogenic ras Acquire the Ability to Grow in a 
Three-dimensional  Manner 
The intestinal rat epithelial cell line, IEC-18, is nontumori- 
genie in nude mice upon subcutaneous (9, 23, 37) or even 
Rak et al. ras Suppression of  Adhesion-regulated Apoptosis  1589 orthotopic (intracecal)  injection  (Rak J., J. Filmus, R.  S. 
Kerbel, unpublished observations). Overexpression of the 
mutant H-ras oncogene (Fig. 1, bottom), alone, resulted in 
the  acquisition  by these  cells  of the  tumorigenic pheno- 
type. This change in in vivo behavior was paralleled by an 
alteration in cell morphology (Fig. 1, A  and D) and a mod- 
erate  (25%)  increase  in  growth rate in  vitro  (91).  How- 
ever,  both  parental  IEC-18  cells  and  their  tumorigenic 
counterparts grow readily under conventional monolayer 
tissue  culture  conditions  (Fig.  1, A  and D).  In confluent 
cultures we observed the ras transfectants, but not the pa- 
rental IEC-18 cells, frequently detached from the bottom 
of tissue culture wells, spontaneously aggregated and con- 
tinued to grow three-dimensionally (Fig.  1, C  and D). To 
elucidate the nature of this difference in behavior, various 
tumorigenic and nontumorigenic sublines of IEC-18 cells 
were generated and examined for their ability to grow in a 
three-dimensional  culture  system i.e.,  as  so-called multi- 
cellular spheroids  (42,  81)  (Fig. 2). In such culture condi- 
tions,  cell adhesion,  spreading,  and  monolayer formation 
on the bottom of the tissue culture dish is prevented by the 
presence of a  thin  layer of solid  agarose; this  forces the 
cells to remain in suspension or to form tumor-like homo- 
typic multicellular aggregates (74). Under these conditions 
the initial aggregation of parental IEC-18 cells was rather 
poor  with  numerous  single  cells  and  small  clumps  sur- 
rounding  a  larger central aggregate. Within  six days, the 
free-floating single cells and small clumps were replaced by 
cellular debris and, the remaining compact, central aggre- 
gate gradually disintegrated.  In contrast,  the  H-ras  trans- 
formed, tumorigenic variants, ras-3, ras-4 and ras-7 readily 
aggregated  and  within  the  first  24  h  in  culture  formed 
three-dimensional spheroids in which all of the cells in the 
well were incorporated.  These cells remained viable and 
metabolically active for several weeks, and in the case of 
high ras expressers (for example ras-7 clone; compare Fig. 
1, bottom and Fig. 2) an apparent rapid increase in  size of 
spheroids over time was consistently observed. 
To examine whether the change in aggregation, spher- 
oid morphology and growth was directly related to expres- 
sion  of  the  oncogenic  ras  we  used  the  IEC-18-derived 
clone carrying an activated H-ras under control of the glu- 
cocorticoid inducible MMTV promoter (IEC-25 or clone 
25  cells).  The clone 25  cells formed spheroids  similar to 
those  of parental  IEC-18  cells  in  the  absence  of dexa- 
methasone (Fig. 2). However, when plated in the presence 
of dexamethasone the cells aggregated and grew on aga- 
rose in a manner indistinguishable from the stable ras trans- 
fectants.  Dexamethasone itself had no effect on parental 
IEC-18 cells (Fig. 2). 
It was puzzling  that  the  ability of ras  transfectants  to 
grow in the spheroid culture was associated with a remark- 
able alteration  in their aggregation properties. In order to 
elucidate  whether  there  is  a  causal relationship  between 
these two characteristics, a nonaggregating variant (ras7A3H 
cell line) was generated (Filmus, J., unpublished  observa- 
tions). These cells, when plated on agarose, formed only a 
layer of single cells or loose clusters rather than spheroids, 
but  they  still  retained  the  ability  to  proliferate  (Fig.  2). 
This observation suggests that aggregation is not essential 
for  enhanced  three-dimensional  growth  capacity  of  the 
H-ras transformed IEC-18 cells. 
Figure 1.  Morphological  features of intestinal  epithelial  cells in monolayer culture  (phase contrast microscopy).  (A) Typical epithelial 
appearance of parental IEC-18 cells. These immortalized rat intestinal epithelial cells are nontumorigenic  but grow readily in monolayer 
culture. Transfection  of IEC-18 with an activated  H-ras oncogene  resulted  in the derivation of transformed clones ras-3 (B), ras-4 (C), 
and ras-7 (D) expressing increasing levels of malignancy in vivo. These ras transformed cells display spindle shaped or round morphol- 
ogy, easily detach from the bottom of the dish and aggregate; bottom panel: Western analysis showing the relative levels of p21 ras protein 
expression by transfected and parental IEC-18 cells. 
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sublines (105 cells/well of the 24-well plate were plated on day 0). (IEC-18) The cells are either incorporated into a larger central spher- 
oid or remain dispersed  as single cells or small aggregates.  -dex, no dexamethasone; +dex, cells plated in the presence of 10  "6 M dexa- 
methasone (no change); (Clone 25) IEC-18 cells transfected with H-ras under control of glucocorticoid inducible promoter. +dex, Addi- 
tion of dexamethasone (10  -6 M) on day 0 resulted in dramatic increase in aggregation,  growth and viability of cells; -dex, in the absence 
of dexamethasone the spheroids  morphology resembles that of IEC-18 cells. (RAS-3, RAS-4, RAS-7) These tumorigenic  variants of 
IEC-18 ceils, stably transfected with the H-ras oncogene, rapidly aggregated and formed large spheroids  in which all the cells are incor- 
porated. The increase in spheroid volume is clearly visible in the case of ras-7 cells that expressed the highest level of transfected ras and 
that are tumorigenic  and metastatic in vivo (71). (RAS-7A3H) A nonaggregating  variant of ras-7 ceils grows in suspension  or as loose 
clusters. 
Nontumorigenic Intestinal Epithelial Cells Undergo a 
Form of Programmed Cell Death in Spheroid Culture 
Despite  residual  cell-cell  adhesion  and  abundance  of 
growth factors in the medium, IEC-18 cells maintained in 
three-dimensional culture displayed  signs of spheroid dis- 
integration and spontaneous cell death, as described above. 
FACS analysis revealed time dependent  abnormalities in 
the  DNA  profile  of cells  recovered  from  disintegrating 
IEC-18 spheroids. Such alterations were not found in cells 
from parallel  monolayers or  cultures  of ras-transformed 
cells (Fig. 3 A). Within 3-4 d of the initiation of the IEC-18 
spheroid  culture  the  majority of the  cells moved to  the 
sub-G1 region. In contrast, monolayer cultures as well as the 
ras-7 cell line  grown as spheroids continued  to express a 
normal DNA profile, with some reduction in S phase and 
marginal fraction of dead cells in the latter case. The time- 
dependent  DNA  degradation  in  IEC-18  spheroids  was 
also  observed  when  the  intact  spheroids  were  collected 
and their DNA resolved on a  1.2%  agarose gel (data not 
shown). No oligonucleosomal sized DNA "ladders" were 
detected,  which  is  not  necessarily surprising  in  this  case 
considering  the  rather  asynchronous nature  of the  DNA 
degradation in  IEC-18 ceils and similar characteristics of 
apoptosis described for other systems (13, 59, 62, 77, 80). 
Changes  in  DNA  integrity  were  accompanied  by  the 
loss of the clonogenic capacity of IEC-18 cells but not, at 
least initially, by any appreciable cell membrane damage 
(Fig. 3 B). While the spheroids still contained trypan blue 
excluding cells after 78-100 h  in culture, the capability of 
these  cells to give rise to clonal colonies was almost en- 
tirely eliminated. No colonies were detected at these later 
time points even after the plating of as many as 105 trypan 
blue excluding cells on plastic. Again, this observation sug- 
gests that the functional death of epithelial cells in spher- 
oid  culture  precedes  and  initially  exceeds  signs  of  cell 
membrane damage (Fig. 3 B).  Morphological features of 
IEC-18 cells in spheroid culture seem to support this con- 
clusion  (Fig.  4).  Thus,  initially,  the  cells recovered from 
IEC-18  spheroids  were  indistinguishable  in  appearance 
from  their  monolayer derived  counterparts  (Fig.  4  A). 
However, after 24-72  h  on  agarose a  gradual  change  in 
morphology began to take place (Fig. 4, B and D). At first 
a moderate enlargement of some of the cells was observed. 
The cytoplasm  of these  cells frequently contained  corn- 
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Figure  3.  (.4)  Programmed 
cell death of IEC-18 cells in 
spheroid  culture.  Time  de- 
pendent  DNA  degradation 
of IEC-18 cells maintained in 
spheroid culture. FACS pro- 
files of the DNA content in 
either monolayer or spheroid 
cultures of IEC-18 and ras-7 
cells  (staining with  propid- 
ium  iodide).  By  day  four, 
IEC-18  ceils  maintained in 
spheroid culture display sub- 
G1 DNA content; arrowhead 
indicates the position of the 
G1  peak;  (B)  Time-depen- 
dent  decrease  in  colony 
forming ability precedes the 
cell membrane damage as in- 
directly measured by trypan 
blue  exclusion and  drop  in 
total cell  recovery.  The via- 
ble cells  were  isolated from 
spheroids and plated at den- 
sities  ranging from  160-105 
cells per 100-mm dish in trip- 
licates; (C) Derivation by se- 
rial selection of programmed 
cell  death  resistant variants 
of IEC-18 cells. The parental 
population was  subjected to 
several rounds of selection in 
spheroid  culture  alternated 
with cell  recovery in mono- 
layer. Independently derived 
cell lines AR-3.4 and AR-1.7 
have  undergone  four  and 
seven  selections,  respec- 
tively,  and  acquired  corre- 
sponding levels of resistance 
to PCD as measured by col- 
ony forming efficiency. 
partments that no longer excluded trypan blue while the 
remaining cytoplasm continued to do so. It is possible that 
this was a result of an engulfment of dead cells by their still 
viable neighbors (87). At the same time a large number of 
cytoplasmic vacuoles was formed. These changes were fol- 
lowed by cell shrinkage and the resulting smaller cells upon, 
staining with the DNA binding dye, Hoechst 33258,  dis- 
played features of chromatin condensation and marginal- 
ization around the nuclear membrane (Fig. 4 C). Finally, 
after 100 h in culture the ability to exclude trypan blue by 
the IEC-18 cells was entirely compromised and the spher- 
oids disintegrated into dead cells, cellular fragments and 
debris.  This  sequence  of events  triggered  by the  three- 
dimensional  culture  conditions  was  clearly indicative of 
programmed cell death and morphologically reminiscent 
of so-called type II apoptosis (10). 
As may have been expected, at the ultrastructural level 
the cells present within dying IEC-18 spheroids were vastly 
different from cells  recovered from monolayer cultures 
(Fig.  5).  Within  the  monolayer cell population multiple 
mitoses were observed and the cells contained numerous 
mitochondria  and  surface  microvilli  (Fig.  5,  A  and  C) 
whereas none of these features was present in spheroids. 
In the latter case the cells were loaded with cytoplasmatic 
vacuoles containing a lipid-like material or in some cases 
membrane-like structures. Finally, the cells maintained in 
spheroid culture for 48-72 h manifested signs of an appar- 
ent apoptotic death with chromatin condensation, nuclear 
fragmentation and  numerous  apoptotic bodies scattered 
throughout the low power field (Fig. 5, B and D). 
Temporal Nature of the Cell Death Process in IEC-18 
Cells Grown as Spheroids 
After ~70 h in spheroid culture the IEC-18 cell  "suicide" 
program reached an irreversible stage. Addition of dexa- 
methasone  to  clone 25  cells  before, but  not  after,  that 
stage resulted in a recovery of the clonogenic capacity and 
The Journal  of Cell Biology,  Volume 131, 1995  1592 Figure 4.  Morphological  features of IEC-18 cells cultured  for 72 h as monolayer (A) or spheroids  (B-D). (A) Single cell suspension of 
monolayer cells; the majority of the cells are viable and do not stain with trypan blue or display morphological abnormalities.  (B and D) 
Cells recovered from spheroid culture display features reminiscent of type II apoptosis (e.g., presence of multiple intracellular  vacuoles) 
(10). Some trypan blue excluding cells contain compartments containing the dye possibly due to engulfment of dead cells by viable cells. 
(C) Staining of the spheroid derived IEC-18 cells with DNA binding dye Hoechst 33258; smaller cells display signs of chromatin conden- 
sation and marginalization  around the nuclear membrane. Arrowheads, trypan blue positive cells; arrow, cytoplasmic vacuoles in the 
"viable" compartment of the cell. Bar, 10 IxM. 
prevented  morphological disintegration  of the  spheroids 
(Table I, Fig. 2). Thus up to 48 h in spheroid culture the in- 
duction of oncogenic ras was able to abort the cell death 
program triggered by three-dimensional culture conditions. 
Since this type of programmed cell death (PCD) seems to 
be unique in that it is initiated in nontransformed epithe- 
lial cells by the absence of normal adhesion and spreading, 
we will  refer to  this  phenomenon  as  adhesion  regulated 
programmed cell death  (ARPCD)  to  distinguish  it from 
PCD induced by other stimuli. 
Selection of Cellular Variants Expressing Spontaneous 
Resistance to ARPCD 
After  four  days  in  spheroid  culture  the  colony forming 
ability of IEC-18 cells is  usually undetectable  (Fig.  3,  B 
and C). We noticed however that when a large number of 
such  spheroid  derived  cells  were  plated,  single  colonies 
could occasionally be found. We hypothesized that these 
surviving cells may represent a  rare, "silent," PCD-resis- 
tant variant present within the IEC-18 cell population. The 
latter population was therefore subjected to a series of se- 
lections  to  enrich  it  for such  putative  ARPCD  resistant 
subpopulations.  The  cells  were  repeatedly  incubated  in 
spheroid culture, which was alternated with periods of re- 
covery in monolayer. The results shown in Fig. 3 C suggest 
that  indeed  ARPCD-resistant  variants  of  IEC-18  cells 
could be isolated  in this manner. In this experiment the 
time dependent survival capacity of two out of three inde- 
pendent variants was evaluated by the  colony formation 
assay. These variants designated AR-3.4 and AR-1.7  have 
undergone four and seven cycles of selection, respectively. 
It is apparent that in both cases the survival is visibly ex- 
tended,  although unlike the ras transfectants, the sponta- 
neous ARPCD-resistance has a limited duration (compare 
Table II). This may be due to contamination of the variant 
cell lines with parental ARPCD-sensitive cells, especially 
since a longer selection resulted in greater resistance and 
presumably higher purity of the late passage AR cell lines. 
Alternatively, the level of expression of the gene(s) antag- 
onizing ARPCD  in  these  cells may have been increased 
during  the  course of the  selection process. By using this 
protocol we were able to obtain variants that survived up 
to  three  months  in  three-dimensional  culture  (data  not 
shown).  Again, in contrast to the ras transfectants, these 
cells did  not  display elongated morphology nor did they 
express any obvious growth advantage in monolayer cul- 
ture. In contrast, on agarose coated surfaces they formed 
Rak et al. ras Suppression of  Adhesion-regulated Apoptosis  1593 Figure 5.  Electron micrograph of IEC-18 cells cultured  for 72 h as monolayer (A and C) or  spheroids  (B and D). (A) Cells recovered 
from monolayer are rich in microvilli, mitochondria (m) and display multiple  mitotic figures (M) (magnification  3,850x).  (B) Section 
through IEC-18 spheroid, magnification 3,850x. The cells are filled with vacuoles (V) containing lipid- or membrane-like material, some 
manifesting different  degrees of apoptotic death 'A'. (C), monolayer cells at the magnification of 10,500x.  (D) Details of the apoptotic 
cell from the field shown in B (magnification 10,500x). Bar, (A and B) ~8 Ixm;  (C and D) 3 Ixm. 
parental-like, small, compact spheroids composed of mostly 
viable but nonproliferating cells (data not shown). 
Transient Rescue of Epithelial CeUs from ARPCD by 
Overexpression of bcl-2 Proto-oncogene 
A  series of bcl-2 transfectants was generated to examine 
whether the overexpression of this gene could (a) abort or 
mitigate the IEC-18 cell death process in spheroid culture 
thus confirming its apoptotic nature  or (b) mimic the be- 
havior  of  the  ras-transfected  or  spontaneous  ARPCD- 
resistant variants. Indeed, the resulting bcl-2 transfectants 
shared some degree of phenotypic similarity with  the lat- 
ter cell lines. The morphology of both types of variants in 
monolayer  was  indistinguishable  from  parental  IEC-18 
cells  (not  shown).  Also,  in  spheroid  culture,  both bcl-2- 
transfected and spontaneous ARPCD resistant cells were 
unable to expand significantly, manifested compact mor- 
phology and had extended but limited survival capability 
(Fig. 6,  Table II). Somewhat surprisingly, neither BCL-2 
(Fig.  6,  bottom)  nor  BCL-X  L protein  (not  shown)  was 
overexpressed in spontaneous  ARPCD-resistant  variants 
implying  that  other  genes  may  be  responsible  for  their 
phenotype. The latter possibility is currently under study. 
Discussion 
Two main conclusions can be drawn from our results. First, 
when nontumorigenic intestinal epithelial cells are grown 
in  a  nonphysiologic circumstance,  i.e.,  as  a  three-dimen- 
sional,  tumor-like  multicellular  aggregate,  the  cells  die 
spontaneously by a  form of programmed cell death.  Sec- 
ond, this adhesion regulated programmed cell death pro- 
cess can be prevented by expression of a mutated ras on- 
cogene. Because oncogenic ras mutations are  a  common 
genetic aberration in cancer, especially colorectal carcino- 
mas, the results have a number of implications. These in- 
clude how ras mutations may contribute  to the  develop- 
ment and progression of solid tumors, the manner in which 
programmed cell death may be regulated, especially by ad- 
hesion, in normal and tumor cell physiology, and for how 
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cells is mitigated by overexpression of the bcl-2 protooncogene. 
Parental IEC-18 cells, control transfectants (vector-cll and vec- 
tor-cl2)  and nonexpresser clones  (bc12-c15, bc12-c16) display  an 
expected,  low survival rate after 64 h in agarose culture.  In con- 
trast, clones expressing BCL-2 protein acquired an increased  sur- 
vival capability similar to the spontaneous ARPCD resistant  cell 
lines (AR-I.10 and AR-2.10). The latter cell lines do not express 
endogenous BCL-2 protein. In this experiment cell viability and 
metabolic activity was evaluated by MT1  ~ assay. SHZ-3-2-5 is a 
human neuroblastoma cell line expressing bcl-2 (which was used 
as a positive control). 
drugs that interfere with the function of mutant ras genes 
or RAS proteins may suppress the growth of solid tumors 
in vivo. 
ARPCD 
In a broad sense our observations point to the fact that not 
only growth but also cellular life and death are under the 
continuous influence of both intracellular and extracellu- 
lar contexts. The specific features of such contexts would 
likely be determined by cell type, the  presence of other 
cells, cell shape, tissue topology and the types of adhesive 
interaction with surrounding  extracellular matrix (ECM) 
molecules  (6,  75,  79).  With respect to cell-ECM interac- 
tions in regulating apoptosis, it is known, for example, that 
adhesion and spreading on ECM is essential for survival of 
endothelial cells (7, 55, 72), certain types of epithelial cells 
in culture (6, 27,  55), or tumor cells (40, 58). ECM medi- 
ated inhibition of apoptosis may be regulated through in- 
tegrin-dependent  modulation  of survival or death  genes, 
e.g., upregulation of bcl-2 (90) or suppression of putative 
cell  death  promoting  elements,  e.g.,  interleukin-ll3  con- 
verting enzyme (6). The presence of an adhesive substrate 
has also been shown to be required for completion of the 
cell cycle (30). In this context our recent observation that 
Table L Time-dependent  Rescue of  lEC-18/Clone 25 Cells from 
PCD in Spheroid Culture by Induction of ras Oncogene 
Expression 
Time of dexamethasone addition after  Number of colonies per 104 cells cultured 
plating cells in 3-D culture  for 124 h on agarose 
h 
0  >>250, >>250, >>250 
30  >>250, >>250, >>250 
48  >250, >250, >250 
70  4,1,1 
96  4, 2,0 
No dexamethasone  0, 0, 0 
2-D control  >>250, ->250, >>250 
Single cell suspension was prepared 124 h after plating cells in 3-D and viable cells 
were seeded in triplicate wells. Colony forming efficiency was determined after 6 d. 
cyclin  D1  is  upregulated  in  ras  transformed  anchorage- 
independent IEC-18 cells may suggest that this cyclin also 
perhaps plays a  role in regulating three-dimensional cell 
survival (22). 
Cell-cell adhesion and aggregation have also been dem- 
onstrated to play a  role in  multicellular  growth and sur- 
vival in  various normal or tumor cell systems (3,  33,  38, 
67). This includes our own earlier studies suggesting that a 
drug-induced  cell  death  pathway  can  be  modified  by 
three-dimensional  cell  growth  (38,  42).  In  these  and  a 
number of other studies it was postulated that specific sig- 
naling events are triggered by cell-cell interaction, cell ad- 
hesion,  and  cell shape changes  that  in  turn  regulate  cell 
growth, or else inhibit programmed cell death  (3, 27, 69, 
70,  75).  Our  present  observations,  suggest  that  the  type 
and molecular consequences of cell adhesion may be more 
important  than  the  adhesion  itself.  Even  a  rather  tight 
cell--cell adhesion in IEC-18 spheroids could not prevent 
activation of apoptotic cell death in three-dimensional cul- 
ture, although it should be noted that the IEC-18 cells that 
were  incorporated  into  spheroids  retained  their  viability 
longer than cells that were not  (compare Fig. 2  and Re- 
suits). In this regard it is noteworthy that in the spheroid 
model used in this study, the  analysis of cell growth and 
survival is performed in a multicellular context where the 
potential for intercellular  adhesion  and  cell--cell interac- 
tion  are preserved.  In most other three-dimensional cul- 
Table II. Transient Rescue of lEC-18 Cells from PCD by 
Expression  of bcl-2 Proto-oncogene 
Relative viability of cells in spheroid culture after 
Cell line examined*  24 h  48 h  72 h 
mean +- SEM 
IEC-18  29.5 -  3.8*  12.7 ±  0.9  7.3  ±  0.3 
IEC-bcI2-cll  60.3 ±  6.1  35.4 ±  1.6  20.0 +- 4.4 
IEC-bcI2-cl2  67.2 ±  1.5  39.8 ±  2.2  28.9 --- 2.8 
IEC-bcl2-cl4  64.1  ±  2.5  32.0 ±  1.6  21.7 ±- 2.4 
ARI.10  47.3 ±  0.9  28.5 ±  2.4  21.3  ±  2.0 
AR2.10  46.6 ±  6.0  33.6 ±  0.2  26.9 ±  0.8 
Ras4  97.2 ±  4.1  ND  201.1  ±  5.9 
* IEC- 18 refers to parental cell line: IEC-bcl2-cl  1; IEC-bcl2-cl2 and IEC-bcl2-cl4 are 
bcl-2 transfectants of 1EC-18 ceils; AR  1.10, AR2.10 are spontaneous selected (adhe- 
sion regulated) cell death-resistant variants of IEC-18 cells; ras-4 is a ras transfected 
clone of IEC-18. 
*Relative viability of cells as measured by MTT assay expressed as percentage of the 
absorbance detected at the time of plating (0 h). 
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or plated onto a  nonadhesive polymer (e.g., polyHEMA) 
without direct contact with one another (27, 67, 81). Thus 
our  results  may be  pertinent  to  gaining  a  better  under- 
standing of classical anchorage-independent growth. Abil- 
ity of single tumor cells, unlike nontransformed epithelial 
(such as IEC-18) or mesenchymal cells, to grow into small 
colonies when plated in soft agar has long been known to 
be an in vitro hallmark of cancer (26). However, the basis 
for  the  inability  of  such  single  nontransformed  cells  to 
grow anchorage  independently  is  unknown  and  intrinsi- 
cally difficult to evaluate:  it could  represent  a  failure to 
survive due to induction of apoptosis, or a simple inability 
of the cell to divide. Our results with preformed spheroids 
suggest that, at least for epithelial cells, the former is the 
more likely possibility. 
Ras Oncogenes as Suppressors of Programmed Cell 
Death in Tumors 
How ARPCD  is activated and  how oncogenic ras muta- 
tions abort this process remain to be determined. The sup- 
pressive influence of ras in programmed cell death has not 
been widely appreciated, partly because the experimental 
data  on  the  role  of mutant  ras  genes in  apoptosis have 
been  somewhat conflicting (1, 20, 21, 27, 57, 76, 84) and be- 
cause of the great emphasis placed on its direct contribu- 
tion  to  cell  division.  In  addition,  molecules  acting  up- 
stream  of  normal  RAS  such  as  v-src  and  Grb-2  were 
shown to affect apoptosis in different systems (18, 27, 57). 
Activated components of the ras signaling pathway such as 
mutant ras itself, activated raf and MAPK kinase invari- 
ably transform cells,  frequently  leading  to  contact  inde- 
pendent growth and formation of three-dimensional solid 
tumors in vivo (8, 51, 53). Moreover, in the case of two hu- 
man colon cancer cell lines called DLD 1 and HCT 116, in 
which the  mutated copy of K-ras was inactivated by ho- 
mologous recombination,  the  ability of the  cells to form 
tumors in nude mice or colonies in soft agar was reduced 
to  much  greater  extent  than  their  mitogenic  activity  in 
monolayer  culture  (78).  Virtually  all  these  results  have 
been interpreted exclusively in the light of the role of the 
ras/MAPK signaling pathway in mitogenesis. However, in 
the case of IEC-18 cells, simple activation of the mitogenic 
pathway seems to be insufficient for survival under three- 
dimensional conditions.  For example, the cells cannot be 
rescued  from ARPCD  by growth  factors present  in  the 
medium or by conditioned medium from H-ras transfected 
(ras-7) cells (data not shown). 
Formation  of  solid  tumors  by  transformed  epithelial 
cells is associated with a drastic change in tissue topology. 
For such a change to occur the ARPCD induction would 
have to be compromised thereby allowing the  transition 
from physiological, monolayer-like alignment of epithelial 
cells to the  three-dimensional configuration characteristic 
of solid tumor masses. Presumably the  apoptosis-antago- 
nizing effect of BCL-2 or BCL-X  L proteins would be ex- 
pected  to  facilitate  this  process.  Paradoxically,  in  breast 
cancer,  melanoma and  some other  types of solid  tumor, 
high levels of bcl-2 expression are associated with a more 
favorable prognosis  rather  than  tumor  progression  (31). 
Such observations cast some doubt as to the dominant or 
exclusive role  of the  aforementioned, classical  apoptosis 
repressor genes, at least insofar as the growth of some types 
of solid tumor in vivo is concerned. It is of course conceiv- 
able  that  activated  ras  may  act  to  suppress  apoptosis 
through its stimulatory effect on transcription or function 
bcl-2 like survival genes (41). However, we have been un- 
able  to detect  any elevation of bcl-2 expression in  H-ras 
transfected IEC-18 cells (not shown). Thus, we favor the 
hypothesis that oncogenic ras itself may play a more direct 
role in cell survival under three-dimensional growth condi- 
tions, both in vitro and in vivo. Consequently the ARPCD 
suppressing and not just the mitogenic effect of ras,  may 
be partly responsible for its role in tumorigenesis in many 
instances. In this regard it is of interest to note that during 
the development of colorectal neoplasia there seems to be 
a direct correlation between the susceptibility of epithelial 
cells to undergo apoptosis and the stage of the disease pro- 
gression (4). Moreover, mutations of the K-ras oncogene 
are found at high frequency in colorectal cancers, and are 
temporally associated with the transition from early ade- 
noma to intermediate  adenoma stage of the disease  (19) 
and coincide with the three-dimensional expansion of the 
tumor  mass.  Consistent  with  this  notion,  recent  studies 
have  demonstrated  that  although  K-ras  mutations  are 
found in ~50% of all cases of colorectal adenocarcinomas, 
such mutations were detectable in only 16% of cases of su- 
perficial-type or "flat" colon tumors (32, 56). This suggests 
that K-ras mutations are  not  strongly selected for unless 
the  lesion  assumes  a  three-dimensional  growth  pattern, 
which would be nonphysiologic for colonic mucosal cells 
and thus require the expression of genes inhibiting sponta- 
neous programmed cell death. However, it is also known 
that in a sizable proportion of solid tumors ras mutations 
are not detectable (19,  63). This suggests that other simi- 
larly dominantly acting genes such as v-src, for example, 
may also  confer resistance  to  ARPCD;  indeed,  there  is 
some preliminary evidence for this hypothesis (27, Mitsu- 
hashi Y., J. Rak, and R. S. Kerbel, unpublished  observa- 
tion). 
Mutant ras Oncogenes as Inhibitors of 
Programmed Cell Death:  Implications for Targeting 
RAS as a Strategy for Anti-Tumor Therapy 
For a number of reasons the apparent anti-apoptotic effect 
of mutated ras may be of practical importance. For exam- 
ple, it could help explain why a  relatively potent in vivo 
antitumor effect on established mutant ras expressing tu- 
mors,  is  exerted  by recently  described  inhibitors  of ras, 
namely, the  protein  farnesyltransferase  inhibitors,  such 
as  the  compound  known  as  L-739,749  (44).  This  drug, 
thought to inhibit posttranslational processing and hence 
membrane localization of RAS proteins, was shown to ex- 
ert a moderate cytostatic effect on ras-transformed cells in 
monolayer culture  (28,  43,  66).  It is possible that in vivo, 
this and other similarly acting compounds (45), may have a 
much more dramatic anti-tumor effect by virtue of their 
ability to induce  a  significant level of apoptosis in tumor 
cells  which,  under  three-dimensional  growth  conditions, 
may depend  on mutated ras oncogene for their survival. 
This may help explain why such drugs, despite being non- 
toxic to  tumor cells in  vitro  (in  monolayer culture)  may 
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established solid tumors in vivo (45). This could also occur 
through such inhibitors having anti-angiogenic properties, 
by  preventing  ras-mediated  upregulation  of  angiogenic 
growth factors (71). 
In summary, three-dimensional, multicellular configura- 
tion can spontaneously activate an adhesion regulated pro- 
cess of programmed cell death in epithelial cells that nor- 
mally grow (in vivo) in a monolayer-like manner. Activated 
ras  can abort this process. These findings implicate ras  on- 
cogenes  as  agents  in  the  development  of  solid  tumors 
through  their  suppressive  influence  in  programmed  cell 
death, and not just by their ability to promote cell prolifer- 
ation per se. Our results also serve to emphasize the need 
to use three-dimensional culture systems when studying in 
vitro the molecular and cellular biology of cell survival in 
solid tumors, and provide a basis for the putative suppres- 
sive influence of activated  ras  oncogenes on spontaneous 
apoptosis in vivo observed in transplanted solid tumors (1, 
87, 88). 
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